AstraZeneca Sues Aurobindo For Nexium Patent Infringement
AstraZeneca AB slammed Aurobindo Pharma Ltd. with a patent infringement lawsuit in New Jersey federal court on Wednesday over the generics maker's versions of Nexium, claiming the company should be barred...To view the full article, register now.
Already a subscriber? Click here to view full article